Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Completed · Phase 3

Conditions studied: Leukaemia, Lymphocytic, Chronic

In brief

The purpose of this study was to evaluate the safety and efficacy of ofatumumab added to fludarabine-cyclophosphamide in patients with relapsed Chronic Lymphocytic Leukemia (CLL).

Key facts

Study ID

NCT00824265

Run by

Novartis Pharmaceuticals

People needed

365

Starts

2009-03-12

Expected to finish

2017-10-25

Last updated by the study team

2020-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novartis Investigative Site — Chicago, Illinois, United States
• Novartis Investigative Site — Clinton, Maryland, United States
• Novartis Investigative Site — Kansas City, Missouri, United States
• Novartis Investigative Site — St Louis, Missouri, United States
• Novartis Investigative Site — Memphis, Tennessee, United States
• Novartis Investigative Site — Brasilia, Goiás, Brazil
• Novartis Investigative Site — Porto Alegre, Rio Grande do Sul, Brazil
• Novartis Investigative Site — São Paulo, São Paulo, Brazil
• Novartis Investigational Site — Porto Alegre, Brazil
• Novartis Investigative Site — Rio de Janeiro, Brazil
• Novartis Investigation Site — Rio de Janeiro, Brazil
• Novartis Investigative Site — Rio de Janeiro, Brazil
• Novartis Investigational Site — São Paulo, Brazil
• Novartis Investigative Site — Pleven, Bulgaria
• Novartis Investigative Site — Plovdiv, Bulgaria
• Novartis Investigative Site — Sofia, Bulgaria
• Novartis Investigational Site — Sofia, Bulgaria
• Novartis Investigational Site — Sofia, Bulgaria
• Novartis Investigative Site — Sofia, Bulgaria
• Novartis Investigative Site — Varna, Bulgaria
• Novartis Investigative Site — New Westminster, British Columbia, Canada
• Novartis Investigative Site — Kitchener, Ontario, Canada
• Novartis Investigative Site — Newmarket, Ontario, Canada
• Novartis Investigative Site — Ottawa, Ontario, Canada
• Novartis Investigative Site — Boca Raton, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.